Placenta Previa or PAS? Test Your Diagnostic Skills – ISUOG
ISUOG International Society of Ultrasound in Obstetrics and Gynecology shared a post on LinkedIn:
“This week’s ISUOG Education quiz question comes from A/Prof. Conrado Coutinho, who will be co-chairing our course ‘Understanding CSP and PAS: concepts, controversies and clinical practice’, taking place 12 April virtually.
A 34-year-old woman, G3P2, with two previous cesarean sections, attends her 22-week ultrasound scan. She reports no other uterine surgeries.
Look at the images below.
What is the most appropriate interpretation of these findings?
A. Normal findings in placenta previa after previous cesarean section.
B. Suspicion of placenta accreta spectrum disorder requiring referral to a specialised PAS centre.
C. Isolated placental lakes without clinical significance.
D. Indication for immediate delivery due to high risk of uterine rupture.
Comment your answer below and come back next Friday to see if your answer is correct!
Register for our upcoming course ‘Understanding CSP and PAS: concepts, controversies and clinical practice’ led by Prof. Amarnath Bhide, A/Prof. Conrado Coutinho and Prof. Ilan Timor-Tritsch here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment